Article Details
Retrieved on: 2020-11-23 15:55:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer and <b>BioNTech</b> announced they had completed their Phase III trial of their COVID-19 vaccine candidate, BNT162b2. This comes only a week ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here